Generation Study

  • STATUS
    Recruiting
  • participants needed
    10
Updated on 19 February 2024

Summary

The Generation study is a clinical research study for individuals ages 60 to 75 with an increased genetic risk of developing clinical symptoms of Alzheimer’s disease. The study is enrolling persons who have two copies of the APOE4 gene An employee of the investigative site or an immediate family member of an employee of the investigative site are not eligible.

Description

Who may be eligible to participate? • Individuals 60-75 years of age who are cognitively normal. • Participants must have a reliable study partner: a spouse, relative, or friend who knows the participant well and sees him or her often, who will attend some study visits, and who will provide information about the participant during the study. Genetic Disclosure Prior to screening, research participants will meet with a genetic counselor to learn their APOE4 genotype status. Screening, which may be spaced out over multiple visits, will determine eligibility. It includes: • a physical/neruological exam • medical history • medication review • electrocardiogram (ECG) • collection of blood and urine • tests of memory and thinking • brain MRI/PET scan Study Activity • This study is comprised of 23 visits over the course of 60 months at the Perelman Center for Advanced Medicine at the Hospital of the University of Pennsylvania. • Participants will receive the study drug six times in the first year and four times in each year after. • Visits can include cognitive testing, blood work, physical and neurological exams, MRI scans and PET scans. Participants will be reimbursed for time and travel.

FAQ

For more information, please visit the following sites: http://www.generationstudy.com/ https://www.endalznow.org/genematch

Details
Condition pre-alzeimers
Age 99years or below
Clinical Study Identifier824975
Last Modified on19 February 2024

Eligibility

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.